A method for compressing molecular tagged sequence data includes: grouping sequence reads associated with a molecular tag sequence to form a family of sequence reads, corresponding vectors of flow space signal measurements and corresponding sequence alignments, calculating an arithmetic mean of the corresponding vectors of flow space signal measurements to form a vector of consensus flow space signal measurements, calculating a standard deviation of the corresponding vectors of flow space signal measurements to form a vector of standard deviations, determining a consensus base sequence based on the vector of consensus flow space signal measurements, determining a consensus sequence alignment and generating a compressed data structure comprising consensus compressed data, the consensus compressed data including for each family, the consensus base sequence, the consensus sequence alignment, the vector of consensus flow space signal measurements, the vector of standard deviations and the number of members.
G16B 20/00 - TIC spécialement adaptées à la génomique ou protéomique fonctionnelle, p. ex. corrélations génotype-phénotype
G16B 20/20 - Détection d’allèles ou de variantes, p. ex. détection de polymorphisme d’un seul nucléotide
G16B 20/40 - Génétique de populationDéséquilibre de liaison
G16B 30/00 - TIC spécialement adaptées à l’analyse de séquences impliquant des nucléotides ou des aminoacides
G16B 30/10 - Alignement de séquenceRecherche d’homologie
G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
G16B 40/10 - Traitement du signal, p. ex. de spectrométrie de masse ou de réaction en chaîne par polymérase
G16B 50/00 - TIC pour la programmation d’outils ou de systèmes de bases de données spécialement adaptées à la bio-informatique
H03M 7/30 - CompressionExpansionÉlimination de données inutiles, p. ex. réduction de redondance
2.
COMPOSITIONS, KITS AND METHODS FOR DETECTION OF VIRAL SEQUENCES
Compositions for detecting the presence of monkeypox virus in a biological sample includes a monkeypox nucleic acid forward primer; a monkeypox nucleic acid reverse primer; and a monkeypox nucleic acid probe. Methods include a multiplex assay including a three-channel panel with a single assay per channel, that includes a monkeypox assay with a reporter and a quencher, a non-variola orthopox assay with a reporter and a quencher, and a RNase P assay with a reporter and a quencher. A kit for detecting monkeypox virus nucleic acid includes the assay components including the forward and reverser primers and probes for each of the three assays in the multiplex assay.
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
C12Q 1/6806 - Préparation d’acides nucléiques pour analyse, p. ex. pour test de réaction en chaîne par polymérase [PCR]
C12Q 1/6825 - Détecteurs faisant intervenir la détection d’acides nucléiques
C12Q 1/686 - Réaction en chaine par polymérase [PCR]
3.
SILICON-SUBSTITUTED RHODAMINE DYES AND DYE CONJUGATES
Silicon-substituted rhodamine compounds are disclosed herein. Also described herein are SIR dyes comprising at least one vinyl group attached to the Si atom (10 position) of the SiR dye. Derivatives, functionalized versions, conjugates, kits, related synthetic methods and uses of SiR compounds also are provided. Silicon-rhodamine (SiR) dyes can provide bright fluorescence at far red wavelengths and exhibit good photostability. The compounds described herein can be useful for fluorescent labeling and detection of biological samples.
C07F 7/08 - Composés comportant une ou plusieurs liaisons C—Si
C07F 9/6561 - Composés hétérocycliques, p. ex. contenant du phosphore comme hétéro-atome du cycle contenant des systèmes de plusieurs hétérocycles déterminants condensés entre eux ou condensés avec un carbocycle ou un système carbocyclique commun, avec ou sans autres hétérocycles non condensés
C12Q 1/6816 - Tests d’hybridation caractérisés par les moyens de détection
G01N 33/58 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des substances marquées
A fluidic device for performing isotachophoresis comprise a sub-strate defining a fluidic network comprising a plurality of inlet channels, the outlets of the inlet channels meeting at a juncture, an intermediate channel extending from the juncture and fluidically coupled to the outlets of the plurality of inlet channels, a first reservoir at the juncture and fluidically coupled to the inlet channels and the intermediate channel, a second reservoir fluidically coupled to the intermediate channel at a location downstream of the juncture, wherein the inlet channels, the collection channel, and the intermediate channel are co-planar, and wherein the first reservoir and second reservoir are configured to produce substantially equal pressure heads. Methods of loading the fluidic device for isotachophoresis can be sequentially through the various inlet channels.
Cell culture media, concentrated media and feeds, methods of manufacturing cell culture media and feeds, and methods of culturing cells are provided. One or more small peptides, including dipeptides are added to the cell culture media to provide improved stability and improved conditions for culturing cells.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion
8.
NON-IONIC SURFACTANTS AND METHODS OF MAKING AND USING THE SAME
Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 323/11 - Thiols, sulfures, hydropolysulfures ou polysulfures substitués par des halogènes, des atomes d'oxygène ou d'azote ou par des atomes de soufre ne faisant pas partie de groupes thio contenant des groupes thio et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné ayant les atomes de soufre des groupes thio liés à des atomes de carbone acycliques du squelette carboné
C08G 65/00 - Composés macromoléculaires obtenus par des réactions créant une liaison éther dans la chaîne principale de la macromolécule
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
9.
NON-IONIC SURFACTANTS AND METHODS OF MAKING AND USING THE SAME
Disclosed here are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 323/11 - Thiols, sulfures, hydropolysulfures ou polysulfures substitués par des halogènes, des atomes d'oxygène ou d'azote ou par des atomes de soufre ne faisant pas partie de groupes thio contenant des groupes thio et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné ayant les atomes de soufre des groupes thio liés à des atomes de carbone acycliques du squelette carboné
C08G 65/00 - Composés macromoléculaires obtenus par des réactions créant une liaison éther dans la chaîne principale de la macromolécule
10.
NON-IONIC SURFACTANTS AND METHODS OF USING THE SAME
Disclosed herein are aspects of a compound according to Formula I. The compounds are useful as surfactants and can be used in applications for which a surfactant is indicated. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are aspects of a method for making the compounds and methods for using the compounds in cell assays.
C07C 43/164 - Éthers non saturés contenant des cycles aromatiques à six chaînons
C08G 65/329 - Polymères modifiés par post-traitement chimique avec des composés organiques
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
11.
NON-IONIC SURFACTANTS AND METHODS OF USING THE SAME
Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 323/11 - Thiols, sulfures, hydropolysulfures ou polysulfures substitués par des halogènes, des atomes d'oxygène ou d'azote ou par des atomes de soufre ne faisant pas partie de groupes thio contenant des groupes thio et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné ayant les atomes de soufre des groupes thio liés à des atomes de carbone acycliques du squelette carboné
C08G 65/00 - Composés macromoléculaires obtenus par des réactions créant une liaison éther dans la chaîne principale de la macromolécule
12.
NON-IONIC SURFACTANTS AND METHODS OF USING THE SAME
The present disclosure provides surfactant-based compositions, methods, kits, and systems for use in cell permeabilization, analytical and diagnostic assays, polypeptide stabilization, viral inactivation, and bioprocess workflows. In certain aspects, permeabilization buffers comprising defined concentrations of nonionic surfactants in polar protic solvents permeabilize diverse cell types while preserving intracellular targets and compatibility with downstream detection chemistry and nucleic acid amplification. Related compositions include loading, blocking, running, and mountant buffers, as well as polypeptide stabilization and viral inactivation solutions formulated with the surfactants. In additional aspects, the surfactants are used in lateral flow devices, bead-based assays, and lipid nanoparticle workflows, including determination of encapsulation efficiency. The disclosure further provides methods and systems in which data generated from surfactant-containing workflows are analyzed by machine-learning processes to determine attributes of buffer performance and recommend protocol parameters.
C07C 43/164 - Éthers non saturés contenant des cycles aromatiques à six chaînons
C08G 65/329 - Polymères modifiés par post-traitement chimique avec des composés organiques
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
13.
NON-IONIC SURFACTANTS AND METHODS OF MAKING AND USING THE SAME
Disclosed herein are aspects of a compound according to Formula (I). tHe compounds are useful as surfactants and can be used in applications for which a surfactant is indicated. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are aspects of a method for making the compounds and methods for using the compounds in cell assays.
Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
C07C 235/44 - Amides d'acides carboxyliques, le squelette carboné de la partie acide étant substitué de plus par des atomes d'oxygène ayant des atomes de carbone de groupes carboxamide liés à des atomes de carbone de cycles aromatiques à six chaînons et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné avec des atomes de carbone de groupes carboxamide et des atomes d'oxygène, liés par des liaisons simples, liés à des atomes de carbone du même cycle aromatique à six chaînons non condensé
15.
NON-IONIC SURFACTANTS AND METHODS OF USING THE SAME
Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
C07C 235/44 - Amides d'acides carboxyliques, le squelette carboné de la partie acide étant substitué de plus par des atomes d'oxygène ayant des atomes de carbone de groupes carboxamide liés à des atomes de carbone de cycles aromatiques à six chaînons et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné avec des atomes de carbone de groupes carboxamide et des atomes d'oxygène, liés par des liaisons simples, liés à des atomes de carbone du même cycle aromatique à six chaînons non condensé
16.
NON-IONIC SURFACTANTS AND METHODS OF USING THE SAME
Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded and can be used as replacements for current surfactants, such as octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Surfactant-based compositions, methods, kits, and systems can be used in cell permeabilization, analytical/diagnostic assays, polypeptide stabilization, viral inactivation, and bioprocess workflows. Permeabilization buffers comprising the compounds, permeabilize diverse cell types while preserving intracellular targets and are compatible with a variety of downstream detection and analysis methods. Compositions include loading, blocking, running, mountant buffers, polypeptide stabilization and viral inactivation solutions. The surfactants are used in lateral flow devices, bead-based assays, and lipid nanoparticle workflows. The disclosure further provides methods and systems in which data generated from surfactant-containing workflows are analyzed by machine-learning processes to determine attributes performance and recommend protocol parameters.
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 323/11 - Thiols, sulfures, hydropolysulfures ou polysulfures substitués par des halogènes, des atomes d'oxygène ou d'azote ou par des atomes de soufre ne faisant pas partie de groupes thio contenant des groupes thio et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné ayant les atomes de soufre des groupes thio liés à des atomes de carbone acycliques du squelette carboné
C08G 65/00 - Composés macromoléculaires obtenus par des réactions créant une liaison éther dans la chaîne principale de la macromolécule
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
17.
NON-IONIC SURFACTANTS AND METHODS OF USING THE SAME
The present disclosure provides surfactant-based compositions, methods, kits, and systems for use in cell permeabilization, analytical and diagnostic assays, polypeptide stabilization, viral inactivation, and bioprocess workflows. In certain aspects, permeabilization buffers comprising defined concentrations of nonionic surfactants in polar protic solvents permeabilize diverse cell types while preserving intracellular targets and compatibility with downstream detection chemistry and nucleic acid amplification. Related compositions include loading, blocking, running, and mountant buffers, as well as polypeptide stabilization and viral inactivation solutions formulated with the surfactants. In additional aspects, the surfactants are used in lateral flow devices, bead-based assays, and lipid nanoparticle workflows, including determination of encapsulation efficiency. The disclosure further provides methods and systems in which data generated from surfactant-containing workflows are analyzed by machine-learning processes to determine attributes of buffer performance and recommend protocol parameters.
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
C07C 235/44 - Amides d'acides carboxyliques, le squelette carboné de la partie acide étant substitué de plus par des atomes d'oxygène ayant des atomes de carbone de groupes carboxamide liés à des atomes de carbone de cycles aromatiques à six chaînons et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné avec des atomes de carbone de groupes carboxamide et des atomes d'oxygène, liés par des liaisons simples, liés à des atomes de carbone du même cycle aromatique à six chaînons non condensé
18.
COMPOSITION, SYSTEM, AND METHOD FOR ADENO-ASSOCIATED VIRUS (AAV) PRODUCTION
Compositions, systems, kits and methods for producing AAV vectors in a suspension at high viral titer and purity. Certain aspects include one or more of media, cells, transfection reagent, viral production enhancer, host cell DNA encapsidation reducer, and lysis buffer, each of which is designed to provide maximal viral particle production with high purity from culture of eukaryotic cells, such as 293 cells and insect cells.
Disclosed herein are aspects of a compound according to Formula I
Disclosed herein are aspects of a compound according to Formula I
Disclosed herein are aspects of a compound according to Formula I
The compounds are useful as surfactants and can be used in applications for which a surfactant is indicated. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are aspects of a method for making the compounds and methods for using the compounds in cell assays.
Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
C09K 23/42 - Éthers, p. ex. éthers polyglycoliques d'alcools ou de phénols
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
C07C 235/48 - Amides d'acides carboxyliques, le squelette carboné de la partie acide étant substitué de plus par des atomes d'oxygène ayant des atomes de carbone de groupes carboxamide liés à des atomes de carbone de cycles aromatiques à six chaînons et des atomes d'oxygène, liés par des liaisons simples, liés au même squelette carboné avec des atomes de carbone de groupes carboxamide et des atomes d'oxygène, liés par des liaisons simples, liés à des atomes de carbone du même cycle aromatique à six chaînons non condensé ayant l'atome d'azote d'au moins un des groupes carboxamide lié à un atome de carbone acyclique d'un radical hydrocarboné substitué par des atomes d'oxygène liés par des liaisons simples
C08G 65/334 - Polymères modifiés par post-traitement chimique avec des composés organiques contenant du soufre
Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
C07C 47/575 - Composés comportant des groupes —CHO liés à des atomes de carbone de cycles aromatiques à six chaînons contenant des groupes éther, des groupes , des groupes ou des groupes
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 43/23 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons contenant des groupes hydroxyle ou O-métal
Systems and methods for autofocus using artificial intelligence include (i) capturing a plurality of monochrome images over a nominal focus range, (ii) identifying one or more connected components within each monochrome image, (iii) sorting the identified connected components based on a number of pixels associated with each connected component, (iv) generating a focus quality estimate of at least a portion of the sorted connected components using a machine learning module, and (iv) calculating a target focus position based on the focus quality estimate of the evaluated connected components. The calculated target focus position can be used to perform cell counting using artificial intelligence, such as by (i) generating a seed likelihood image and a whole cell likelihood image based on output—a convolutional neural network and (ii) generating a mask indicative quantity and/or pixel locations of objects based on the seed likelihood image.
G06T 3/40 - Changement d'échelle d’images complètes ou de parties d’image, p. ex. agrandissement ou rétrécissement
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
G06V 20/69 - Objets microscopiques, p. ex. cellules biologiques ou pièces cellulaires
A method for biological sample analysis includes receiving reference nucleic acid sequence information and biological sample nucleic acid sequence data, comparing the biological sample nucleic acid sequence data to the reference nucleic acid sequence information, outputting overall consensus metrics of the biological sample nucleic acid sequence data and the reference nucleic acid sequence information based on the comparison and outputting one or more region level consensus metrics of one or more regions of each of the biological sample nucleic acid sequence data and the reference nucleic acid sequence information.
THERMO FISHER ELECTRON SCIENTIFIC INSTRUMENTS LLC (a Delaware corporation) (USA)
LIFE TECHNOLOGIES CORPORATION (a Delaware corporation) (USA)
Inventeur(s)
Irwin, Julian James
Smith, Wesley Glen
Abrégé
Methods and apparatuses dynamic range enhancement of fluorescence detectors are described herein. In one aspect, a method can include collecting, from a sample during a sample event, an emission spectrum that comprises a plurality of emission signals; based on reception times associated with emission signals of the plurality of emission signals, determining a lifetime estimation for the sample; determining, based at least on the lifetime estimation, a pileup factor affecting receiving emissions from the sample; and based on the determined pileup factor, adjusting a number of emission signals measured during the sample event to generate an estimated number of emissions for the sample event.
Described herein are methods for separating analytes by applying an electric field to one or more samples in a liquid or semi-liquid separation matrix shared by the one or more samples.
The present invention relates to a system for detecting a defect in a fluid-filled specimen. The system includes a fluid conveying device in fluid communication with the specimen to fill it with a fluid. A first electrode is disposed outside the specimen, and a portion of a second electrode is disposed inside the specimen. Further, a detector assembly is in electrical communication with the first and second electrodes, and the detector assembly is configured to detect the defect in the specimen.
The present invention relates to an apparatus for detecting a defect in a test area of a test specimen. The apparatus includes a first electrode, the first electrode being disposed external to the test specimen, a second electrode, at least a portion of the second electrode being disposed within the test specimen, and a detector assembly in electrical communication with the first and second electrodes. The detector assembly includes a voltage generator configured (a) to generate a voltage and (b) to supply the voltage to the first electrode, and a measuring tool configured to detect the defect in the test area of the test specimen by detecting an electrical circuit between the first and second electrodes.
Methods for evaluating microsatellite instability (MSI) analyze nucleic acid sequence reads corresponding to a plurality of marker regions for MSI. The marker regions may include long homopolymers and/or short tandem repeats (STRs). For a target homopolymer, a histogram of homopolymer signal values is calculated based on flow space signal measurements for the homopolymer region in the sequence reads. A score per marker based on features of the histogram of homopolymer signal values is determined for each marker region corresponding to the target homopolymers. For a target STR, the method includes calculating a histogram of repeat lengths for sequence reads corresponding to the marker region of the target STR. A score per STR marker is calculated based on features of the histogram of repeat lengths. A plurality of per marker scores may be combined to form a total MSI score for the sample.
C12Q 1/6809 - Méthodes de détermination ou d’identification des acides nucléiques faisant intervenir la détection différentielle
C12Q 1/6886 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique pour le cancer
G16B 20/00 - TIC spécialement adaptées à la génomique ou protéomique fonctionnelle, p. ex. corrélations génotype-phénotype
Described herein are automated capping and de-capping systems and methods of use thereof. Automated capping and de-capping systems include a rack-support unit operable to support at least two types of a rack, a head unit comprising a plurality of cap-drivers, and a drive system. Each rack is operable to support a plurality of tubes having caps, the caps being a first cap type or a second cap type. The second cap type is different than the first cap type. The cap-drivers include a first interface portion operable to engage with the first cap type and a second interface portion operable to engage with the second cap type. The drive system is for moving the rack-support unit and the head unit relative to each other to facilitate engagement between the cap-drivers and the caps of the tubes to cap or de-cap the tubes.
B65B 7/28 - Fermeture de réceptacles ou récipients semi-rigides ou rigides, non déformés par le contenu ou n'en prenant pas la forme, p. ex. boîtes ou cartons en appliquant des fermetures séparées préformées, p. ex. couvercles, capuchons
35.
QUANTIFICATION OF TARGETS USING CYCLE-BY-CYCLE DATA COLLECTED ON A DIGITAL POLYMERASE CHAIN REACTION PLATFORM
A method for quantification of a target molecule of a biological sample distributed across a plurality of partitions is provided. The method includes receiving fluorescent emission data generated by a polymerase chain reaction (PCR) for each partition of a set of partitions and identifying a partition quantity metric for each partition in the set of partitions to generate a set of partition quality metrics. Each partition quantity metric correlates to a number of target molecules within its respective partition based on the fluorescent emission data. The set of partition quantity metrics is used to determine a state of target molecule amplification within each partition of the set of partitions. The method further includes determining a quantity of the target molecule in the biological sample based on the set of partition quantity metrics.
A bioproduction mixing system includes a flexible compartment having a first end, a second end, and a sidewall extending therebetween, a center axis passing through the flexible compartment between the first end and the second end. A helical assembly is disposed within the flexible compartment and is suspended between the first end and the second end, the helical assembly being offset from the center axis of the flexible compartment.
C12M 1/42 - Appareils pour le traitement de micro-organismes ou d'enzymes au moyen d'énergie électrique ou ondulatoire, p. ex. magnétisme, ondes sonores
B01F 23/233 - Mélange de gaz avec des liquides en introduisant des gaz dans des milieux liquides, p. ex. pour produire des liquides aérés en utilisant des agitateurs entraînés munis d’éléments d'agitation complètement immergés
B01F 27/054 - Agitateurs déformables, p. ex. déformés par une force centrifuge appliquée en cours de fonctionnement
B01F 27/114 - Agitateurs de forme hélicoïdale, c.-à-d. agitateurs comprenant une bande de forme hélicoïdale ou des sections de bande de forme hélicoïdale
B01F 27/213 - Mélangeurs à agitateurs tournant dans des récipients fixesPétrins caractérisés par leurs arbres de rotation caractérisés par la liaison avec l'entraînement
B01F 27/90 - Mélangeurs à agitateurs tournant dans des récipients fixesPétrins avec des agitateurs tournant autour d'un axe sensiblement vertical avec des palettes ou des bras
B01F 27/92 - Mélangeurs à agitateurs tournant dans des récipients fixesPétrins avec des agitateurs tournant autour d'un axe sensiblement vertical avec des hélices ou des vis
B01F 35/41 - Montage ou support des arbres d'agitation ou des unités d'agitation sur les récipients
B01F 35/43 - Récipients de soutien sur des cadres ou des supports
B01F 35/513 - Récipients souples, p. ex. sacs supportés par des conteneurs rigides
B01F 101/44 - Mélange d'ingrédients pour la microbiologie, l'enzymologie, la culture in vitro ou la manipulation génétique
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
C12M 1/06 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens d'introduction de gaz avec agitateur, p. ex. avec agitateur à turbine
C12M 1/36 - Appareillage pour l'enzymologie ou la microbiologie comportant une commande sensible au temps ou aux conditions du milieu, p. ex. fermenteurs commandés automatiquement
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
Described herein are automated capping and de-capping systems and methods of use thereof. Automated capping and de-capping systems include a rack-support unit operable to support at least two types of a rack, a head unit comprising a plurality of cap-drivers, and a drive system. Each rack is operable to support a plurality of tubes having caps, the caps being a first cap type or a second cap type. The second cap type is different than the first cap type. The cap-drivers include a first interface portion operable to engage with the first cap type and a second interface portion operable to engage with the second cap type. The drive system is for moving the rack-support unit and the head unit relative to each other to facilitate engagement between the cap-drivers and the caps of the tubes to cap or de-cap the tubes.
Methods and systems for data distribution are described herein. In one aspect, a method can include receiving, by at least one worker node (WN) 110 of a plurality of WNs of a data distribution system, a job definition from a job manager, wherein the job definition comprises a set of processes to be performed on a set of data request; sending, by the WN 110 and to an extended binary access manager (BAMEx) 140, a request for the data; receiving, by the WN 110 and from the BAMEx 140, the data based on the request for the data; performing, by the WN 110, one or more processes according to the job definition; generating, by the WN 110, a set of results files comprising results of at least one of the performed one or more processes; and sending, by the WN 110, the set of results files to the BAMEx 140.
A system includes a central administration module, a biological sample assay instrument, and a biological sample analysis module communicatively coupled to each other, where the central administration module may include: at least one processor; and at least one memory, where the at least one memory contains instructions configuring the at least one processor to: store an instrument user profile and an analysis user profile in a data store; verify a user of the biological sample assay instrument based on the stored instrument user profile; and verify a user of the biological sample analysis module based on the stored analysis user profile. Systems and methods for biological sample analysis include elements for enabling multi-platform authentication and sample analysis auditing.
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
44.
SYSTEMS AND METHODS FOR MULTIPLEXED POLYMERASE CHAIN REACTION PROCESSES AND DATA ANALYSIS
Systems and methods that enable analyte detection in a multiplexed amplification process can include obtaining, at multiple time points during the amplification process, composite fluorescence signal data associated with a composite fluorescence signal from at least a first probe type comprising a first fluorophore and a second probe type comprising a second fluorophore which has substantially overlapping spectral characteristics as said first fluorophore, the first probe type and the second probe type differing in thermal and/or temporal properties; and determining, based at least partially on the composite fluorescence signal data, fluorescence signal data associated with a fluorescence signal from a given probe type of the first probe type or the second probe type during the amplification process.
Provided herein are, inter alia, compositions and methods useful for the in vivo delivery of bioactive agents (e.g., therapeutic or diagnostic agents). The compositions provided herein include cationic lipids, helper lipids and a biostability enhancing agent, which together form a lipid aggregate with the bioactive agent and allow for the systemic delivery of the bioactive agent to, for example, spleen tissue without the requirement for biomolecular targeting.
A61K 47/69 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament le conjugué étant caractérisé par sa forme physique ou sa forme galénique, p. ex. émulsion, particule, complexe d’inclusion, stent ou kit
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 9/1272 - Liposomes non conventionnels, p. ex. liposomes modifiés par un PEG ou liposomes enduits de ou greffés avec des polymères comprenant des agents tensioactifs non phosphatidyliques comme substances formant des bicouches, p. ex. lipides cationiques ou liposomes non phosphatidyliques enduits de ou greffés avec des polymères
A61K 31/7105 - Acides ribonucléiques naturels, c.-à-d. contenant uniquement des riboses liés à l'adénine, la guanine, la cytosine ou l'uracile et ayant des liaisons 3'-5' phosphodiester
A61K 31/713 - Acides nucléiques ou oligonucléotides à structure en double-hélice
A61K 47/54 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique
A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
C12N 15/88 - Introduction de matériel génétique étranger utilisant des procédés non prévus ailleurs, p. ex. co-transformation utilisant la micro-encapsulation, p. ex. utilisant des vésicules liposomiques
47.
SYSTEMS AND METHODS FOR DETECTING NUCLEOTIDE INCORPORATION
A system includes a fluidic system configured to flow a plurality of reagent solutions; an imaging apparatus in communication with the fluidic system, the imaging apparatus comprising an array of image sensors, an array of wells disposed over the array of image sensors, and a flow cell structure defining a flow space over the array of wells; and a data collection circuitry to receive light signal data from the imaging apparatus.
B01L 7/00 - Appareils de chauffage ou de refroidissementDispositifs d'isolation thermique
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
B01L 3/00 - Récipients ou ustensiles pour laboratoires, p. ex. verrerie de laboratoireCompte-gouttes
G01N 21/00 - Recherche ou analyse des matériaux par l'utilisation de moyens optiques, c.-à-d. en utilisant des ondes submillimétriques, de la lumière infrarouge, visible ou ultraviolette
Methods and compositions for purifying a nucleic acid preparation. The methods include contacting a nucleic acid preparation including single-stranded ribonucleic acid (ssRNA) with a double-stranded ribonucleic acid binding protein (dsRBP) that specifically binds to double-stranded ribonucleic acid (dsRNA) and is optionally immobilized on a solid support before or after the dsRBP-dsRNA complex is formed to remove dsRNA from a mixed nucleic acid preparation.
The application describes bioreactors comprising gas permeable membranes disposed on the housing covering at least partially a transfer opening. The bioreactor is also provided with a mixing element and ports adapted to receive sensors measuring values of parameters related to the process implemented in the bioreactor. The bioreactor comprises at least one opening in one of the walls. The at least one opening is covered with a gas permeable membrane.
C12M 1/36 - Appareillage pour l'enzymologie ou la microbiologie comportant une commande sensible au temps ou aux conditions du milieu, p. ex. fermenteurs commandés automatiquement
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
C12M 1/06 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens d'introduction de gaz avec agitateur, p. ex. avec agitateur à turbine
C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
52.
METHODS AND SYSTEMS OF DETERMINING OPTIMAL AMPLIFICATION CYCLE NUMBERS
Provided herein are methods and systems of determining an optimal amplification cycle number during an amplification reaction of a template with unknown concentrations, thereby generating an amplification output within a narrow concentration range and desired quantities regardless of its initial template input. The optimal amplification cycle number can be determined based on a transition point corresponding to a change in signals of the amplification reaction. The transition point can be determined based on applying a derivative to the signals of the amplification, determining a baseline of the signals, or a combination thereof.
C12Q 1/6848 - Réactions d’amplification d’acides nucléiques caracterisées par les moyens d’empêcher la contamination ou d’augmenter la spécificité ou la sensibilité d’une réaction d’amplification
Provided herein are methods and systems of determining an optimal amplification cycle number during an amplification reaction of a template with unknown concentrations, thereby generating an amplification output within a narrow concentration range and desired quantities regardless of its initial template input. The optimal amplification cycle number can be determined based on a transition point corresponding to a change in signals of the amplification reaction. The transition point can be determined based on applying a derivative to the signals of the amplification, determining a baseline of the signals, or a combination thereof.
C12Q 1/6848 - Réactions d’amplification d’acides nucléiques caracterisées par les moyens d’empêcher la contamination ou d’augmenter la spécificité ou la sensibilité d’une réaction d’amplification
54.
THERMO-RESPONSIVE POLYMER FOR USE IN BIOLOGICAL APPLICATIONS AND METHOD OF MAKING AND USING THE SAME
Thermo-responsive polymers that can be used to provide extracellular matrices for cell/organoid growth and/or for using in isolating/purifying biomolecules. Also disclosed are methods for making and using the polymers. The thermo-responsive polymers exhibit the ability to transition between different phases with changes in temperature and thus provide the ability to grow cells/organoids and then be easily separated from the cells/organoids without destroying them. The thermo-responsive polymer facilitates isolating biomolecules from contaminants that might be produced in biological assays.
A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
A61K 47/58 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique macromoléculaire, p. ex. une molécule oligomérique, polymérique ou dendrimérique obtenu par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. poly[méth]acrylate, polyacrylamide, polystyrène, polyvinylpyrrolidone, alcool polyvinylique ou résine d’acide sulfonique de polystyrène
C08F 2/38 - Polymérisation utilisant des régulateurs, p. ex. des agents d'arrêt de chaîne
C08F 293/00 - Composés macromoléculaires obtenus par polymérisation sur une macromolécule contenant des groupes capables d'amorcer la formation de nouvelles chaînes polymères rattachées exclusivement à une ou aux deux extrémités de la macromolécule de départ
G01N 33/00 - Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes
55.
SAMPLE PREPARATION COMPOSITIONS, DEVICES, SYSTEMS AND METHODS
The present specification relates to compositions, devices, apparatus, methods, kits and systems for sample preparation (e.g., separation, reduction or removal of small molecules from biomolecules in a sample). Exemplary small molecules that can be separated, reduced or removed have a molecular weight range of <2000 Da. and may include, but are not limited to, dyes, biotin, affinity tags, crosslinkers, reducing agents, labels, nanoparticles, radioactive ligands, mass tags, unreacted molecules and combinations, intermediates and derivatives of the foregoing. Exemplary biomolecules present in a sample, include but are not limited to, proteins, glycoproteins, antibodies, peptides, nucleic acids, polysaccharides, carbohydrates and lipids. Methods, compositions, kits, devices, apparatus and systems of the disclosure may advantageously provide superior separation of small molecule contaminants and additionally reduce time and expenses related to separation of small molecules from larger biomolecules in samples. Biomolecules separated as set forth herein are amenable to better downstream processing.
A method of culturing cells for vaccine production comprises culturing cells in the presence of microcarriers with cell culture media and infecting the cells with a virus. The microcarrier comprises a bead and a coating. The coating comprises a thermo-responsive polymer having a lower critical solution temperature (LCST) of between about 20 °C and about 34 °C. The cells adhere to the coating of the microcarrier at a temperature above the LCST. The microcarrier comprises a polymeric bead, and a hydrophobic polymer. The hydrophobic polymer is a block copolymer which is connected to the bead by a covalent bond or by physical adsorption. The block copolymer comprises at least one hydrophobic block and at least one thermo-responsive block.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
A61K 39/205 - Rabdoviridae, p. ex. virus de la rage
A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
A61K 47/58 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique macromoléculaire, p. ex. une molécule oligomérique, polymérique ou dendrimérique obtenu par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. poly[méth]acrylate, polyacrylamide, polystyrène, polyvinylpyrrolidone, alcool polyvinylique ou résine d’acide sulfonique de polystyrène
C08F 2/38 - Polymérisation utilisant des régulateurs, p. ex. des agents d'arrêt de chaîne
C08F 293/00 - Composés macromoléculaires obtenus par polymérisation sur une macromolécule contenant des groupes capables d'amorcer la formation de nouvelles chaînes polymères rattachées exclusivement à une ou aux deux extrémités de la macromolécule de départ
G01N 33/00 - Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes
57.
COMPRESSION COLLAR EXPANDER ASSEMBLY AND METHOD OF USE
Various embodiments of a compression collar expander assembly for expanding a tubular compression collar are described. For example, the compression collar expander assembly can include a guide plate, a spindle plate, and a plurality of carriages movably disposed on a top surface of the guide plate. Each of the plurality of carriages can include a body, a guide projecting from the body, and a die set comprising a plurality of dies. Each die can include a base coupled to a corresponding one of the plurality of carriages and a prong upstanding from the base. In some embodiments, a tapered expander is configured to assist with expanding the plurality of dies.
B21D 39/20 - Dispositifs de mandrinage des tubes avec des mandrins, p. ex. expansibles
B21D 39/04 - Utilisation de procédés permettant d'assembler des objets ou des parties d'objets, p. ex. revêtement par des tôles, autrement que par placageDispositifs de mandrinage des tubes des tubes avec des tubesUtilisation de procédés permettant d'assembler des objets ou des parties d'objets, p. ex. revêtement par des tôles, autrement que par placageDispositifs de mandrinage des tubes des tubes avec des barres
58.
OVEN AND GRIPPER DESIGN FOR BIOLOGICAL ANALYSIS INSTRUMENT
A biological analysis system for analyzing a biological sample is provided. The system includes a sample holder including a position identifier set, including a first, second, and third position identifier. The system further includes an oven, and a gripper arm system configured to move a sample holder between functional areas of the biological analysis system. The oven includes an outer housing, an inner housing, and an air gap between the outer housing and the inner housing. The oven further includes a heater configured to supply heat to the biological sample and a heat circulating assembly configured to circulate heated air within the housing around the biological samples. The gripper arm system includes an optical sensor configured to measure the position of each position identifier and a processor for determining an x, y, and z position of each position identifier to generate an adjusted coordinate system for controlling the gripper arm.
A method of installing a flexible bioprocess container in a bioprocessing system having a rigid housing with an interior compartment and extending between a top and an opposing base. The method includes coupling a first surface of the flexible bioprocess container to a moveable platform positioned within the interior compartment of the rigid housing; coupling a second surface of the flexible bioprocess container to the base of the rigid housing; and moving the movable platform relative to the rigid housing and toward the top of the rigid housing so as to at least partially expand the flexible bioprocess container within the interior compartment of the rigid housing.
C12M 1/42 - Appareils pour le traitement de micro-organismes ou d'enzymes au moyen d'énergie électrique ou ondulatoire, p. ex. magnétisme, ondes sonores
B01F 23/233 - Mélange de gaz avec des liquides en introduisant des gaz dans des milieux liquides, p. ex. pour produire des liquides aérés en utilisant des agitateurs entraînés munis d’éléments d'agitation complètement immergés
B01F 27/054 - Agitateurs déformables, p. ex. déformés par une force centrifuge appliquée en cours de fonctionnement
B01F 27/114 - Agitateurs de forme hélicoïdale, c.-à-d. agitateurs comprenant une bande de forme hélicoïdale ou des sections de bande de forme hélicoïdale
B01F 27/213 - Mélangeurs à agitateurs tournant dans des récipients fixesPétrins caractérisés par leurs arbres de rotation caractérisés par la liaison avec l'entraînement
B01F 27/90 - Mélangeurs à agitateurs tournant dans des récipients fixesPétrins avec des agitateurs tournant autour d'un axe sensiblement vertical avec des palettes ou des bras
B01F 27/92 - Mélangeurs à agitateurs tournant dans des récipients fixesPétrins avec des agitateurs tournant autour d'un axe sensiblement vertical avec des hélices ou des vis
B01F 35/41 - Montage ou support des arbres d'agitation ou des unités d'agitation sur les récipients
B01F 35/43 - Récipients de soutien sur des cadres ou des supports
B01F 35/513 - Récipients souples, p. ex. sacs supportés par des conteneurs rigides
B01F 101/44 - Mélange d'ingrédients pour la microbiologie, l'enzymologie, la culture in vitro ou la manipulation génétique
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
C12M 1/06 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens d'introduction de gaz avec agitateur, p. ex. avec agitateur à turbine
C12M 1/36 - Appareillage pour l'enzymologie ou la microbiologie comportant une commande sensible au temps ou aux conditions du milieu, p. ex. fermenteurs commandés automatiquement
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
60.
OPTICAL IMAGING SENSOR ALIGNMENT FOR AN EPIFLUORESCENCE MICROSCOPE
A method for aligning an optical imaging sensor for an epifluorescence microscope is provided. The method includes receiving an image of a target pattern of an alignment target positioned near a microscope objective lens. The method further includes determining an image quality for each element of the target pattern and generating a heatmap for the image based on the determined image quality for each element of the target pattern. The heatmap indicates focusing quality and variation over a field-of-view of the objective lens. The method further includes determining focusing metrics based on fitting the heatmap to a distribution profile, and providing the focusing metrics to a user, where the focusing metrics are used to adjust alignment of the optical imaging sensor to improve image quality.
Methods and system are described for normalizing and creating correction factors for measurements in a fluorometer. To ensure that measurements across multiple channels can be properly compared, some kind of calibration must be done. The same calibrant can be run across all the channels and fluorescence measured. The fluorescence of one channel can be chosen as a reference. A correction factor can be calculated for each channel and used for an extended period of time, possibly even the lifetime of the instrument.
G01N 33/96 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir un étalon de contrôle du sang ou du sérum
62.
SYSTEMS, METHODS, AND ASSEMBLIES FOR CELL PROCESSING
Functionally closed integrated system for performing a cell processing assay, a consumable assembly for use therewith, and methods of processing cells to perform an assay, such as a cell isolation, cell de-beading, or cell electroporation assay. The integrated system includes a counterflow centrifugation subsystem fluidically coupled to, and integrated with a bead processing subsystem, and optionally an electroporation subsystem. The counterflow centrifugation subsystem and the bead processing subsystem are contained in a unitary housing having a mounting surface with a valve assembly for receiving a consumable assembly, a rotating motor head operable to apply a rotational force to a separation chamber of the consumable assembly, a pump, an electromagnet, a rocker assembly, a central processor operable to control automation of the system, and optionally one or more of, a temperature control unit, and/or sensors for detecting a parameter of fluid within a fluid path of the consumable assembly.
C12M 3/06 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus avec des moyens de filtration, d'ultrafiltration, d'osmose inverse ou de dialyse
C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
C12M 1/34 - Mesure ou test par des moyens de mesure ou de détection des conditions du milieu, p. ex. par des compteurs de colonies
C12M 1/02 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens d'agitationAppareillage pour l'enzymologie ou la microbiologie avec des moyens d'échange de chaleur
C12N 15/87 - Introduction de matériel génétique étranger utilisant des procédés non prévus ailleurs, p. ex. co-transformation
Disclosed herein are scientific instrument support systems, related methods, computing devices and computer-readable media. A method of mitigating distortion of an optical emission spectrum obtained from an optical emission spectrometer is provided. The method may comprise a step of obtaining a spectrum recorded with the spectrometer and a respective one or more condition parameters indicative of an operating condition at a time of recording the spectrum. The method may further comprise a step of providing a model configured to output, in response to the one or more condition parameters, one or more transform parameters of a transformation to be applied to the obtained spectrum. A transformation may be applied in accordance with the obtained one or more transform parameters to the obtained spectrum to mitigate distortion of the spectrum due to a discrepancy between the operating condition and a baseline operating condition.
Provided herein are, inter alia, methods for preparing a liquid cell culture media that has lesser lot-to-lot analytical variation, increased performance, and has lesser metal ion concentrations compared to a liquid media prepared by traditional methods. Such liquid media may be used for culturing cells, including but not limited to, recombinant cells.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
69.
LENS SYSTEM FOR COLLECTION OF LIGHT FOR SPECTRAL ANALYSIS, AND RELATED DEVICES, SYSTEMS, AND METHODS
Optical systems and methods for collecting light use a collection lens system. An objective lens component of the collection lens system is configured to collect emitted light from a particle in an interrogation region, after irradiation with light from an illumination source. The objective lens component is configured to collect the light in differing spectral ranges and transmit the collected light in a direction of a z-axis of the lens system. An imaging lens component of the collection lens system is configured to receive the light from the objective lens component and transmit the received light in multiple paths corresponding to the differing spectral ranges to a plane at which a detector array is located. The collection lens system is configured to provide substantially constant magnification over a path of light transmitted through the collection lens system to the plane of the detector array.
A transient protein expression system and kit, a composition for producing a recombinant protein in cultured cells, and a method for producing a recombinant protein in cultured cells. The method includes: transfecting 293 cells in a suspension culture having a high density culture medium with a nucleic acid capable of expressing a recombinant protein; contacting the transfected 293 cells with at least one expression enhancer composition; and culturing the transfected 293 cells in the presence of the at least one expression enhancer composition for a period of time such that the recombinant protein is expressed.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion
An assembly for gel electrophoresis includes a gel cassette and a comb. The gel cassette includes a retainer plate and a divider plate coupled to form a cavity therebetween. The comb includes an elongated body having a first end and a second end, an intermediate portion connected to the elongated body and extending between the first and second ends, the intermediate portion having a third end adjacent the first end and a fourth end adjacent the second end, and a plurality of teeth extending from the intermediate portion. The plurality of teeth is spaced apart from at least one of the third end and the fourth end. In response to the comb being received in the gel cassette, the intermediate portion is received in the cavity such that the third and the fourth ends are configured to engage an internal edge of the cavity.
An assembly for gel electrophoresis includes a gel cassette and a comb. The gel cassette includes a retainer plate and a divider plate coupled to form a cavity therebetween. The comb includes an elongated body having a first end and a second end, an intermediate portion connected to the elongated body and extending between the first and second ends, the intermediate portion having a third end adjacent the first end and a fourth end adjacent the second end, and a plurality of teeth extending from the intermediate portion. The plurality of teeth is spaced apart from at least one of the third end and the fourth end. In response to the comb being received in the gel cassette, the intermediate portion is received in the cavity such that the third and the fourth ends are configured to engage an internal edge of the cavity.
Water-soluble, fluorescent particles and compositions, kits, and methods of making and using such particles are disclosed. Processes for preparing fluorescent particles and for controlling the size, polydispersity and optical properties of such particles also are provided.
C09K 11/02 - Emploi de substances particulières comme liants, revêtements de particules ou milieux de suspension
C09B 67/00 - Traitements, sans réaction chimique, influençant les propriétés physiques, p. ex. de teintures ou d'impression, des matières colorantes, p. ex. traitement par des solvantsCaractéristiques du procédé de fabrication des préparations tinctorialesPréparations tinctoriales ayant un aspect physique particulier, p. ex. tablettes, feuilles
C09K 11/06 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances organiques luminescentes
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
G01N 33/533 - Production de composés immunochimiques marqués avec un marqueur fluorescent
G01N 33/58 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des substances marquées
H04L 12/18 - Dispositions pour la fourniture de services particuliers aux abonnés pour la diffusion ou les conférences
H04L 67/10 - Protocoles dans lesquels une application est distribuée parmi les nœuds du réseau
The method includes compressing numbers of reads data for targeted genes of a gene expression assay performed on a test sample. The targeted genes are organized into categories. Each category represents a functional context associated with the targeted genes in that category. The numbers of reads corresponding to targeted genes each category is compressed to form a compressed value for the category. The compressed value is compared to a baseline value for the category to determine an enrichment or a loss of a signature corresponding to the functional context of the category. The method may include analyzing information from multiple assays performed on the test sample, assigning a score value to each assay result and predicting a response to immune-oncology treatment based on the assigned scores.
The present disclosure provides methods, compositions and kits as well as systems for manipulating nucleic acids, including implementing isothermal amplification, such as recombinase-polymerase amplification (RPA), of a nucleic acid template using a pre-seeded solid support. Provided are rapid and efficient methods for generating template nucleic acid molecules comprising specific nucleotide sequence bound to solid support. Such methods can be used, for example, in manipulating nucleic acids in preparation for analysis methods that utilize monoclonal populations of nucleic acids.
A computer-implemented method for monitoring a biological analysis is provided. The method includes receiving image data of a first portion of a set of reaction sites and determining fluorescence from the image data. The method further includes displaying, on a user interface, a first graphical visualization of determined fluorescence in each reaction site of the first portion and receiving a selection of a subset of reaction sites from the set of reaction sites from a user. The method also includes displaying, on the user interface, in response to the selection, a graphical visualization of the subset of the set of reaction sites, where the graphical visualization of the subset includes an indication of progress of receiving image data in each reaction site of the subset and an indication of determined fluorescence of each reaction site in the subset.
Recombinant nucleic acids, compositions and methods for producing polynucleotides, such as donor sequences, as well as their use in a variety of applications including genome engineering.
C12N 15/64 - Méthodes générales pour la préparation du vecteur, pour son introduction dans la cellule ou pour la sélection de l'hôte contenant le vecteur
Systems and methods that enable analyte detection in a multiplexed amplification process can include obtaining, at multiple time points during the amplification process, composite emission signal data associated with a composite emission signal from at least a first probe type comprising a first label configured to generate a first emission signal and a second probe type comprising a second label configured to generate a second emission signal which has spectrally similar characteristics as said first emission signal. the first probe type and the second probe type differing in thermal and/or temporal properties; and determining, based at least partially on the composite emission signal data, emission signal data associated with a emission signal from a given probe type of the first probe type or the second probe type during the amplification process.
An in vitro method, composition and kit for determining the presence or absence of adenovirus, metapneumovirus, rhinovirus/enterovirus, and parainfluenza in a sample, including providing a reaction mixture containing the sample and at least one primer pair set. The primer pair set includes at least one primer pair A that specifically amplifies a portion of adenovirus genome; at least one primer pair B that specifically amplifies a portion of metapneumovirus genome; at least one primer pair C that specifically amplifies a portion of rhinovirus/enterovirus genome; and at least one primer pair D that specifically amplifies a portion of parainfluenza genome. The reaction mixture is subjected to reaction conditions suitable to amplify targeted nucleic acids, thereby generating at least one amplicon; wherein the presence or absence of at least one amplicon in the sample indicates the presence or absence of adenovirus, metapneumovirus, rhinovirus/enterovirus, and/or parainfluenza in the sample.
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
C12Q 1/48 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir une transférase
C12Q 1/686 - Réaction en chaine par polymérase [PCR]
90.
COMPOSITIONS, KITS, AND METHODS FOR DETECTING NUCLEIC ACIDS USING INTRA-CHANNEL MULTIPLEXING
Disclosed are compositions, kits, and methods that enable intra-channel multiplexing by enabling determination of separate detectable signals, each associated with a different assay target, within the same detection channel. The multiple detectable signals can be separately resolved and independently analyzed to enable detection and/or quantification of each respective target. Enabling multiple targets to be assayed within the same detection channel increases the plexy of multiplex assays without relying on additional dyes and concomitant issues of increased spectral overlap.
A system for robotic laboratory operations includes a stationary surface (2) adjacent laboratory equipment and at least one mover (4) configured to perform an action upon a payload atop the stationary surface (2). The action includes but is not limited to translation across at least a portion of the stationary surface. The at least one mover (4) has a drive member (12) configured to drive the translation a carrier that is mounted to the drive member and has a top surface configured to carry a pay load (8). The drive member (12) is configured to drive the at least one mover (4) across the at least the portion of the stationary surface (2) for moving the payload relative to the laboratory equipment.
G01N 35/00 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet
G01N 35/10 - Dispositifs pour transférer les échantillons vers, dans ou à partir de l'appareil d'analyse, p. ex. dispositifs d'aspiration, dispositifs d'injection
95.
Systems, Methods, And Devices For Automated Nucleic Acid And Protein Isolation
Purifying target biomolecules, such as nucleic acids or proteins, from a biological source is a time intensive process and is typically performed by a skilled technician or scientist owing to the highly technical nature of the work. Systems, devices, and methods disclosed herein enable the automated bioprocessing and purification of target biomolecules from a biological source. For example, an instrument and disposable cartridge are provided for automatedly isolating and purifying nucleic acids (such as plasmid DNA from a bacterial culture) or for isolating protein from any biological sample. Such an exemplary instrument and cartridge can work in concert to timely release, mix, and move the target biomolecule and various reagents and buffers through a target biomolecule purification process, resulting in a purified target biomolecule with less manual oversight than traditional approaches.
G01N 35/10 - Dispositifs pour transférer les échantillons vers, dans ou à partir de l'appareil d'analyse, p. ex. dispositifs d'aspiration, dispositifs d'injection
B01D 69/02 - Membranes semi-perméables destinées aux procédés ou aux appareils de séparation, caractérisées par leur forme, leur structure ou leurs propriétésProcédés spécialement adaptés à leur fabrication caractérisées par leurs propriétés
G01N 35/00 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet
96.
CHARACTERIZATION AND OPTIMIZATION OF FLOW CYTOMETRY VOLTAGES
Methods and systems for characterization and optimization of flow cytometry voltages are described herein. According to one aspect of the present disclosure, a method can include applying a plurality of voltages to a detector of a flow cytometry system, the detector optionally comprising a photomultiplier tube (PMT); with the detector, collecting emissions of at least one standard caused by exciting the at least one standard, the at least one standard optionally comprising a bead; measuring a robust coefficient of variance (rCV) for intensity levels of the collected emissions across the plurality of applied voltages; identifying, as an operating voltage setting, a voltage setting where the rCV is essentially asymptotic; and setting the applied voltage of the detector to the identified operating voltage setting.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Chemicals for use in industry and science; diagnostic
preparations for scientific or research use; DNA polymerase,
reagents and reagent kits comprising generic DNA circle, DNA
polymerase and buffers for scientific, medical or veterinary
research use; DNA polymerase, reagents and reagent kits
comprising generic DNA circle, DNA primers, DNA polymerase
and buffers for use in the biotechnology field. Diagnostic preparations for clinical or medical laboratory
use.
Disclosed herein are scientific instrument support systems, as well as related methods, computing devices, and computer-readable media. A scientific instrument support apparatus is disclosed comprising generating logic to generate mass spectrum data during a tandem mass tag labeling experiment including a plurality of channels, determining logic to determine, in the generated mass spectrum data, a correction ratio between a first reporter ion peak intensity corresponding to a first non-deuterated tag and a second reporter ion peak intensity corresponding to a first deuterated tag, and normalizing logic to normalize reporter ion intensities corresponding to a second non-deuterated tag and a second deuterated tag based on the determined correction ratio.
A targeted panel with low sample input requirements from a tumor only sample may be processed to estimate mutation load in a tumor sample. The method may include: detecting variants in nucleic acid sequence reads corresponding to targeted locations in the tumor sample genome; annotating detected variants with an annotation information from a population database; filtering the detected variants, wherein the filtering retains the somatic variants and removes germline variants; calculating an initial TMB; and applying a calibration to the initial TMB level to produce a final TMB level for the mutation load of the tumor sample genome. The filtering may also include retaining nonsynonymous SNVs and indels for the analysis.